## Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages* Nitric oxide (NO) plays a key role in mediating macrophage cytotoxicity towards different targets, including tumoral cells and intracellular pathogens. However, its role in macrophage immunoregulation is less
Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning
✍ Scribed by Zhi-Yong Chen; Li Wang; Pundit Asavaritkrai; Constance Tom Noguchi
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 638 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Erythropoietin (Epo), known to stimulate erythroid progenitor cell survival, proliferation, and differentiation, has been shown to be neuroprotective against brain ischemia in animal models. Both Epo and Epo receptor (EpoR) are expressed in the brain and are up‐regulated by hypoxia. Brain Epo signaling can stimulate neural cell survival and prevent neuron apoptosis. Neurons from EpoR null mice exhibit marked increased sensitivity to hypoxia. In endothelial cells, Epo has been shown to stimulate nitric oxide (NO) production, particularly at low pO~2~. We found here that the EpoR expression on neural cells and Epo's neuroprotective effect were regulated by NO. Hypoxia increased NO production as well as EpoR expression, and inhibition of NOS activity reduced the proportion of EpoR‐expressing neurons induced at low pO~2~. Conversely, addition of NO donor to cultures grown under normoxia induced EpoR. Similarly, NO donor increased EpoR promoter activity in a reporter gene assay, suggesting that NO regulates EpoR at the transcription level. Preincubation of neurons with NO results in induction of EpoR, which gives rise to protection against hypoxia even in the absence of exogenous Epo, although at high concentration NO is toxic. These data provide evidence of a role for NO in Epo activity in brain and suggest links between NO production, EpoR expression, and Epo signaling in neuroprotection. Published 2010 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Tumour hypoxia is associated with resistance to therapy and with increased invasion and metastatic potential. Recent studies in our laboratory have shown that the hypoxic up‐regulation of tumour cell invasiveness and chemoresistance is in part due to reduced nitric oxide (NO) signaling.
## Abstract Exposure of human lung cells to carcinogenic nickel compounds in the presence of oxygen up‐regulated carbonic anhydrase IX (CA IX) and NDRG1/Cap43, both known as intrinsic hypoxia markers and cancer‐associated genes. This suggests that factors other than a shortage of oxygen may be invo
## Abstract The proliferation‐specific Forkhead box M1 (FoxM1) transcription factor is overexpressed in cancer cells and acts as an important regulator of cancer cell growth and survival. Here, we show the molecular mechanisms by which hypoxia regulate FoxM1 expression in cancer cells. When cells w
## Abstract Nitric oxide has been shown to play an important role in regulation of bone resorption. However, the role of endogenous nitric oxide on osteoclast activity remains still controversial. In this work, using RT‐PCR amplification, we demonstrated that rabbit mature osteoclasts express mRNA